Anti-MRSA agent 14 [CAS 3050586-22-3]

Anti-MRSA agent 14 (Compound C17) has antibacterial agent against MRSA and MRSA-infected skin murine model. Anti-MRSA agent 14 is more potential than Norfloxacin against MRSA. Anti-MRSA agent 14 disrupts cell membrane and restrains metabolism. Anti-MRSA agent 14 shows antibacterial effects against S. aureus ATCC 6538, S. aureus ATCC 29213, S. epidermidis ATCC 12228, and MRSA with MIC values of 1, 2, 2, 1 μM respectively[1].

[3050586-22-3]

C43H53ClN2O5S

745.41

CC1(C)CC[C@]2(C(NS(C3=CC=C(Cl)C=C3)(=O)=O)=O)CC[C@@]4(C)[C@]5(C)CC[C@@]6([H])C(C)(C)C7=C(C(C=CC=C8C(O)=O)=C8N7)C[C@]6(C)[C@@]5([H])CC=C4[C@]2([H])C1

Bacterial

Room temperature